Skip to content

Investigating the impact of topical vitamin D on anogenital warts

The effectiveness of topical vitamin D3 and cryotherapy in comparison with cryotherapy in treating anogenital warts

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230124057201N4
Enrollment
30
Registered
2023-11-25
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genital warts. Anogenital (venereal) warts

Interventions

Intervention 1: Intervention group: Patients in addition to four cryotherapy sessions will use vitamin D ointment (calciderm) twice a day. the interventions will continue for three months. Interventio

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Definite diagnosis of HPV Patients with more than two genital warts in genitalia (perinea, groin, anus) Age more than 18 Willingness to participate in the study

Exclusion criteria

Exclusion criteria: Inflammatory skin disease Rheumatological disease Malignancy Kidney and liver disease Eczema Diabetes mellitus Previous history of allergy to vitamin D Acquired immunodeficiency Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Measuring size and number of anogenital warts. Timepoint: Baseline visit, then every three week up to four sessions. Method of measurement: Lesion count, surgical grading ruler.

Secondary

MeasureTime frame
Qualitative evaluation of response to treatment (complete response, partial response 50-99%, no response less than 50%). Timepoint: Last treatment session. Method of measurement: Qualitative.;Patient's satisfaction. Timepoint: Last treatment session. Method of measurement: Qualitative evaluation (Very satisfied, Satisfied, Somehow satisfied, Unsatisfied).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zeinab Aryanian

Tehran University of Medical Sciences

z_aryanian@yahoo.com+98 21 5563 0553

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026